| Quantifiable TCR repertoire changes in pre-diagnostic blood specimens among high-grade ovarian cancer patients |
Bo Li |
Children's Hospital of Philadelphia |
PLCO |
Sep 10, 2026 |
2025-0079 |
| Integration of omics data and lifestyle factors to assess lung cancer risk among former smokers |
Xiao Ou Shu |
Vanderbilt University Medical Center |
PLCO |
Sep 10, 2026 |
2025-0054 |
| Estimating prostate cancer screening, diagnostic follow-up, and detection processes for a natural-history microsimulation model |
ALEX BRYANT |
Regents of the University of Michigan |
PLCO |
Sep 8, 2026 |
PLCO-2077 |
| Prostate Cancer Risk Stratification Using Needle Core Biopsy or Radical Prostatectomy Specimens (Continuation of PLCOI-2074) |
Uttara Joshi |
AIRA Matrix Private Limited |
PLCO |
Sep 8, 2026 |
PLCOI-2080 |
| Evaluating the Impact of Differential LDCT Screening Uptake, Adherence, and Novel Treatment Access on Racial/Ethnic Disparities in Lung Cancer Outcomes: A Modeling Study |
Michael Leo |
Oregon Health & Science University |
PLCO |
Sep 8, 2026 |
PLCO-2072 |
| Artificial Intelligence (AI)-Assisted Health Informatics to Stratify Population for Early Screening of Cancer |
Wazir Muhmmad |
Florida Atlantic University |
PLCO |
Aug 31, 2026 |
PLCO-2067 |
| Artificial Intelligence (AI)-Assisted Health Informatics to Stratify Population for Early Screening of Cancer (Sibling Project to PLCO-2067) |
Gregory Hart |
University of Guam |
PLCO |
Aug 31, 2026 |
PLCO-2078 |
| Estimating lung cancer screening as treatment guidelines change |
Jon Steingrimsson |
Brown University |
NLST |
Aug 31, 2026 |
NLST-1531 |
| Evaluate Artera’s Deep Learning clinical-histologic system as a prognostic classifier for colorectal cancer patients |
Douglas Peters |
Artera Inc. |
PLCO |
Aug 24, 2026 |
PLCOI-2073 |
| External Validation of Foundation Model-Derived Histologic Phenotypes in Prostate Pathology Images |
Olmo Zavala Romero |
Florida State University |
PLCO |
Aug 24, 2026 |
PLCOI-2063 |
| Parameter-Efficient Fine-Tuning of a 3D CT Foundation Model for Lung Cancer Risk Prediction |
Akash Pattnaik |
HOPPR AI |
NLST |
Aug 24, 2026 |
NLST-1528 |
| Explanation-Based Selective Referral in Bimodal Lung Cancer Risk Prediction Using Clinical and Low-Dose CT Data |
Abdul Sadka |
Aston University |
NLST |
Aug 24, 2026 |
NLST-1529 |
| Digital Twin–Enabled Prediction of Toxicity and Tumor Control in Prostate Cancer Radiotherapy |
Samantha Rincon Sabatino |
InfotechSoft |
PLCO |
Aug 24, 2026 |
PLCOI-2075 |
| Diagnostic Pathways for Lung Cancer |
Pamela Marcus |
NCI |
NLST |
Aug 20, 2026 |
NLST-1523 |
| Multi-Omics Profiling of Per- and Polyfluoroalkyl Substances and Chemical Exposures in Relation to Bladder and Upper Tract Urothelial Cancer Risk |
Jongeun Rhee |
Henry M. Jackson Foundation for the Advancement of Military Medicine (Center for Prostate Disease Research, Murtha Cancer Center Research Program) |
MACS |
Aug 17, 2026 |
2026-0140 |
| Serum concentrations of per- and polyfluoroalkyl substances and kidney cancer risk: A nested case-control study among military aviators and aviation support personnel |
Jonathan Hofmann |
National Cancer Institute |
MACS |
Aug 17, 2026 |
2026-0131 |
| Machine Learning to Refine Breast Staging for Prediction of Axillary Node Status and Prognosis |
Mark Sherman |
Mayo Clinic, Jacksonville, Florida |
PLCO |
Aug 10, 2026 |
PLCOI-2066 |
| A federated data analysis framework for surrogate endpoint evaluation |
Edmund Njeru Njagi |
The University of Warwick |
NLST |
Aug 10, 2026 |
NLST-1527 |
| Virtual Staining–Enabled Macrophage Profiling in Ovarian & Lung Cancer |
Anant Madabhushi |
Emory University |
PLCO |
Jul 27, 2026 |
PLCOI-2068 |
| Adherence to the 2018 World Cancer Research Fund (WCRF)/American Institute for Cancer Research (AICR) Cancer Prevention Recommendations and risk of mortality in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial |
Fiona Malcomson |
Newcastle University |
PLCO |
Jul 27, 2026 |
PLCO-2069 |
